No room to breathe: the importance of lung hyperinflation in COPD
M Thomas, M Decramer, DE O'Donnell - Primary Care Respiratory …, 2013 - nature.com
Patients with chronic obstructive pulmonary disease (COPD) are progressively limited in
their ability to undertake normal everyday activities by a combination of exertional dyspnoea …
their ability to undertake normal everyday activities by a combination of exertional dyspnoea …
Pharmacologic treatment of chronic obstructive pulmonary disease: past, present, and future
MA Faulkner, DE Hilleman - Pharmacotherapy: The Journal of …, 2003 - Wiley Online Library
Pharmacologic treatment of chronic obstructive pulmonary disease (COPD) has evolved
considerably during the past several decades. Initial treatment of the disease was …
considerably during the past several decades. Initial treatment of the disease was …
Automatic replacement of albuterol nebulizer therapy by metered-dose inhaler and valved holding chamber
L Hendeles, RC Hatton, TJ Coons… - American Journal of …, 2005 - academic.oup.com
Purpose. Evidence supporting the delivery of bronchodilators with a metered-dose inhaler
and a valved holding chamber (MDI+ VHC) in place of a small-volume nebulizer (SVN) is …
and a valved holding chamber (MDI+ VHC) in place of a small-volume nebulizer (SVN) is …
[HTML][HTML] Comparison of the effects of nebulised and inhaled salbutamol on breathlessness in severe COPD
PJ Poole, R Saini, SM Brodie, PN Black - Respiratory medicine, 2005 - Elsevier
Background: Patients with chronic obstructive pulmonary disease (COPD) often report
greater relief of breathlessness with nebulised bronchodilators than with the same medicine …
greater relief of breathlessness with nebulised bronchodilators than with the same medicine …
Dose‐response to salbutamol via a novel palm sized nebuliser (Aerodose® Inhaler), conventional nebuliser (Pari LC Plus) and metered dose inhaler (Ventolin™ …
BJ Lipworth, EJ Sims, K Taylor… - British journal of …, 2005 - Wiley Online Library
Aims The Aerodose® inhaler is a novel, palm‐sized, breath actuated device which requires
little patient coordination. This study compared the dose–response of salbutamol delivered …
little patient coordination. This study compared the dose–response of salbutamol delivered …
复方硫酸沙丁胺醇气雾剂治疗COPD 的多中心临床研究
王培兰， 马秀清， 余秉翔， 刘又宁， 张波， 高和… - 军医进修学院学报, 2006 - cqvip.com
目的: 评价国产复方硫酸沙丁胺醇气雾剂与进口可必特气雾剂治疗慢性阻塞性肺病(COPD)
患者的临床疗效和安全性及两者是否生物等效. 方法: 在3 所医院进行多中心, 随机盲法 …
患者的临床疗效和安全性及两者是否生物等效. 方法: 在3 所医院进行多中心, 随机盲法 …
复方硫酸沙丁胺醇气雾剂治疗哮喘的多中心临床研究
王培兰， 马秀清， 余丙翔， 刘又宁， 张波， 高和， 姜淑娟 - 解放军医学杂志, 2007 - cqvip.com
目的评价国产复方硫酸沙丁胺醇气雾剂与进口可必特气雾剂治疗轻, 中度支气管哮喘患者的临床
疗效和安全性及两者是否生物等效. 方法在三所医院进行多中心, 随机盲法, 平行对照研究 …
疗效和安全性及两者是否生物等效. 方法在三所医院进行多中心, 随机盲法, 平行对照研究 …
葛根素对急性脑梗死患者血清C 反应蛋白水平的影响及意义
章昕， 徐融 - 现代中西医结合杂志, 2005 - cqvip.com
目的研究葛根素对急性脑梗死患者血清C 反应蛋白含量的影响, 并分析其临床意义. 方法选择84
例经CT 或MRI 确诊的急性脑梗死患者, 随机分为2 组, 2 组均予常规治疗, 治疗组在此基础上予 …
例经CT 或MRI 确诊的急性脑梗死患者, 随机分为2 组, 2 组均予常规治疗, 治疗组在此基础上予 …
慢性阻塞性肺疾病患者呼吸中枢驱动能力与呼吸功能及生活质量关系的研究
张明生， 朱宝玉， 钟晓鹏， 马辉 - 现代中西医结合杂志, 2005 - cqvip.com
目的探讨口腔阻断压(p 0.1) 评估慢性阻塞性肺疾病(COPD) 患者生活质量, 运动耐量,
肺功能严重程度, 血气等相关因素价值. 方法全部病例按GOLD 分级标准分为3 组: ⅡA 级组, ⅡB …
肺功能严重程度, 血气等相关因素价值. 方法全部病例按GOLD 分级标准分为3 组: ⅡA 级组, ⅡB …
Ipratropium treatment of acute airways disease
GM Peterson, PJ Boyles… - Annals of …, 2003 - journals.sagepub.com
OBJECTIVE: To examine the use of ipratropium bromide in adults with acute exacerbation of
either asthma or chronic obstructive pulmonary disease (COPD) during admission and at …
either asthma or chronic obstructive pulmonary disease (COPD) during admission and at …